{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:51:18Z","timestamp":1791186678123,"version":"4.1.0"},"reference-count":124,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R21 NS141756"],"award-info":[{"award-number":["R21 NS141756"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 CA262311"],"award-info":[{"award-number":["R01 CA262311"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P01 CA118816"],"award-info":[{"award-number":["P01 CA118816"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P50 CA097257"],"award-info":[{"award-number":["P50 CA097257"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["UH3 CA298961"],"award-info":[{"award-number":["UH3 CA298961"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["U54 CA302452"],"award-info":[{"award-number":["U54 CA302452"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Trenchard Family Charitable Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Meningiomas are among the few intracranial tumors that are more common in females than males. The majority of meningiomas express progesterone receptor (PR), and differences in exposure to progestogens are thought to contribute to sex-based disparity in meningioma. Previous epidemiological and clinical data have demonstrated that multiple progestins, such as cyproterone acetate (CPA), are linked to meningioma. More recently, international epidemiological studies have found a significantly increased risk of meningioma with depot medroxyprogesterone acetate (DMPA), a widely used injectable contraceptive sold under the trade name Depo-Provera. Although the absolute risk of meningioma remains small, exposure to DMPA increases the risk of meningioma by 1.5- to 5.5-fold. DMPA-associated meningiomas are clinically significant, as the risk of craniotomy for tumor resection, not just the risk of tumor diagnosis, is elevated after DMPA exposure. These data suggest that DMPA should be avoided in individuals with a history of meningioma when alternatives are available. The risk of meningioma should be discussed with patients during DMPA counseling, and the utility of screening patients with prolonged DMPA exposure for meningiomas should be investigated. Further work is needed to elucidate the mechanisms of PR signaling in meningioma and to understand the complex interplay of tumor genomics, hormone exposure and signaling, and social and structural drivers of health that may contribute to disparities in meningioma.<\/jats:p>","DOI":"10.1093\/neuonc\/noag115","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:39:27Z","timestamp":1779190767000},"page":"2338-2351","source":"Crossref","is-referenced-by-count":2,"title":["Epidemiological and clinical data link depot medroxyprogesterone acetate to meningioma"],"prefix":"10.1093","volume":"28","author":[{"given":"Brooke C","family":"Braman","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, University of California, San Francisco , San Francisco, California,","place":["USA"]},{"name":"Department of Neurological Surgery, University of California, San Francisco , San Francisco, California,","place":["USA"]},{"name":"Department of Pathology, University of California, San Francisco , San Francisco, California,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6052-2466","authenticated-orcid":false,"given":"Martha A","family":"Cady","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of California, San Francisco , San Francisco, California,","place":["USA"]},{"name":"Department of Neurological Surgery, University of California, San Francisco , San Francisco, California,","place":["USA"]},{"name":"Department of Pathology, University of California, San Francisco , San Francisco, California,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1652-3848","authenticated-orcid":false,"given":"Allison A","family":"Merz-Herrala","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology & Reproductive Sciences, University of California, San Francisco , San Francisco, California,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0231-1050","authenticated-orcid":false,"given":"Alon","family":"Witztum","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of California, San Francisco , San Francisco, California,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zora","family":"Arum","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of California, San Francisco , San Francisco, California,","place":["USA"]},{"name":"Department of Neurological Surgery, University of California, San Francisco , San Francisco, California,","place":["USA"]},{"name":"Department of Pathology, University of California, San Francisco , San Francisco, California,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scarlett L","family":"Gomez","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of California, San Francisco , San Francisco, California,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8464-6041","authenticated-orcid":false,"given":"Ramin A","family":"Morshed","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, University of California, San Francisco , San Francisco, California,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5910-0757","authenticated-orcid":false,"given":"Javier E","family":"Villanueva-Meyer","sequence":"additional","affiliation":[{"name":"Department of Radiology and Biomedical Imaging, University of California, San Francisco , San Francisco, California,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8302-5008","authenticated-orcid":false,"given":"Nancy Ann Oberheim","family":"Bush","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, University of California, San Francisco , San Francisco, California,","place":["USA"]},{"name":"Department of Neurology, University of California, San Francisco , San Francisco, California,","place":["USA"]},{"name":"Division of Neuro-Oncology, University of California, San Francisco , San Francisco, California,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2084-3959","authenticated-orcid":false,"given":"Susan M","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, University of California, San Francisco , San Francisco, California,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4399-3893","authenticated-orcid":false,"given":"Jennifer L","family":"Kerns","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology & Reproductive Sciences, University of California, San Francisco , San Francisco, California,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9299-8864","authenticated-orcid":false,"given":"David R","family":"Raleigh","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of California, San Francisco , San Francisco, California,","place":["USA"]},{"name":"Department of Neurological Surgery, University of California, San Francisco , San Francisco, California,","place":["USA"]},{"name":"Department of Pathology, University of California, San Francisco , San Francisco, California,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"2026100502515796300_noag115-B1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noaf194","article-title":"CBTRUS statistical report: primary brain and other Central nervous system tumors diagnosed in the United States in 2018\u20132022","volume":"27","author":"Price","year":"2025","journal-title":"Neuro-Oncol"},{"key":"2026100502515796300_noag115-B2","doi-asserted-by":"publisher","first-page":"118","DOI":"10.5414\/NP301160","article-title":"Clinicopathologic features of incidental meningiomas: a review of the literature and the University of Rochester autopsy experience","volume":"38","author":"Johnson","year":"2019","journal-title":"Clin Neuropathol"},{"key":"2026100502515796300_noag115-B3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0090-3019(87)90005-X","article-title":"Incidental meningiomas in autopsy study","volume":"27","author":"Nakasu","year":"1987","journal-title":"Surg Neurol"},{"key":"2026100502515796300_noag115-B4","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1056\/NEJMoa070972","article-title":"Incidental findings on brain MRI in the general population","volume":"357","author":"Vernooij","year":"2007","journal-title":"N Engl J Med"},{"key":"2026100502515796300_noag115-B5","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1093\/jnci\/djae253","article-title":"Grade-stratified meningioma risk among individuals who are non-Hispanic Black and interactions with male sex","volume":"117","author":"Walsh","year":"2025","journal-title":"JNCI J Natl Cancer Inst"},{"key":"2026100502515796300_noag115-B6","doi-asserted-by":"publisher","first-page":"i5","DOI":"10.1093\/noajnl\/vdad020","article-title":"The joint impacts of sex and race\/ethnicity on incidence of grade 1 versus grades 2\u20133 meningioma across the lifespan","volume":"5","author":"Walsh","year":"2023","journal-title":"Neurooncol Adv"},{"key":"2026100502515796300_noag115-B7","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2026.0507","article-title":"Prospective genomic profiling consecutive meningiomas","author":"Nguyen","year":"2026","journal-title":"JAMA Oncol"},{"key":"2026100502515796300_noag115-B8","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3171\/2024.1.JNS231633","article-title":"Variations in the genomic profiles and clinical behavior of meningioma by racial and ethnic group","volume":"141","author":"Tabor","year":"2024","journal-title":"J Neurosurg"},{"key":"2026100502515796300_noag115-B9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/s0002-9610(38)91219-x","article-title":"Meningiomas. Their classification, regional behaviour, life history, and surgical end results","author":"Cushing","year":"1938","journal-title":"Hafner"},{"key":"2026100502515796300_noag115-B10","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41588-022-01061-8","article-title":"Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities","volume":"54","author":"Choudhury","year":"2022","journal-title":"Nat Genet"},{"key":"2026100502515796300_noag115-B11","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/neuonc\/noab213","article-title":"A molecularly integrated grade for meningioma","volume":"24","author":"Driver","year":"2022","journal-title":"Neuro-Oncol"},{"key":"2026100502515796300_noag115-B12","doi-asserted-by":"publisher","first-page":"6025","DOI":"10.1038\/s41467-025-60734-0","article-title":"Distribution of copy number alterations and impact of chromosome arm call thresholds for meningioma","volume":"16","author":"Patel","year":"2025","journal-title":"Nat Commun"},{"key":"2026100502515796300_noag115-B13","doi-asserted-by":"publisher","first-page":"6024","DOI":"10.1038\/s41467-025-61063-y","article-title":"Pan-cancer copy number analysis identifies optimized size thresholds and co-occurrence models for individualized risk stratification","volume":"16","author":"Nguyen","year":"2025","journal-title":"Nat Commun"},{"key":"2026100502515796300_noag115-B14","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/neuonc\/noae239","article-title":"Meningiomas: sex-specific differences and prognostic implications of a chromosome X loss","volume":"27","author":"Berghaus","year":"2025","journal-title":"Neuro-Oncol"},{"key":"2026100502515796300_noag115-B15","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1093\/neuonc\/noaf002","article-title":"Genomic features underlying meningioma sex-specificity","volume":"27","author":"Raleigh","year":"2025","journal-title":"Neuro-Oncol"},{"key":"2026100502515796300_noag115-B16","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.3171\/2023.3.JNS221838","article-title":"A systematic review and individual participant data meta-analysis of gonadal steroid hormone receptors in meningioma","volume":"139","author":"Miyagishima","year":"2023","journal-title":"J Neurosurg"},{"key":"2026100502515796300_noag115-B17","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1053\/jcpa.2002.0572","article-title":"Immunohistochemical identification and image analysis quantification of oestrogen and progesterone receptors in canine and feline meningioma","volume":"127","author":"Mandara","year":"2002","journal-title":"J Comp Pathol"},{"key":"2026100502515796300_noag115-B18","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.2460\/ajvr.2003.64.1310","article-title":"Evaluation of progesterone and estrogen receptor expression in 15 meningiomas of dogs and cats","volume":"64","author":"Adamo","year":"2003","journal-title":"Am J Vet Res"},{"key":"2026100502515796300_noag115-B19","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1210\/jcem-45-4-814","article-title":"Sex differences in corticosteroids in man","volume":"45","author":"Sch\u00f6nesh\u00f6fer","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"key":"2026100502515796300_noag115-B20","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/sj.bjc.6600098","article-title":"Ethnic differences in ovulatory function in nulliparous women","volume":"86","author":"Haiman","year":"2002","journal-title":"Br J Cancer"},{"key":"2026100502515796300_noag115-B21","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1210\/jc.2011-1314","article-title":"Estrogen levels are higher across the menstrual cycle in African-American women compared with Caucasian women","volume":"96","author":"Marsh","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2026100502515796300_noag115-B22","doi-asserted-by":"publisher","first-page":"101060","DOI":"10.1016\/j.yfrne.2023.101060","article-title":"Progesterone and contraceptive progestin actions on the brain: a systematic review of animal studies and comparison to human neuroimaging studies","volume":"69","author":"Pletzer","year":"2023","journal-title":"Front Neuroendocrinol"},{"key":"2026100502515796300_noag115-B23","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.steroids.2011.02.002","article-title":"Nomegestrol acetate, a novel progestogen for oral contraception","volume":"76","author":"Mueck","year":"2011","journal-title":"Steroids"},{"key":"2026100502515796300_noag115-B24","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2165\/11532130-000000000-00000","article-title":"Nomegestrol acetate: pharmacology, safety profile and therapeutic efficacy","volume":"70","author":"Lello","year":"2010","journal-title":"Drugs"},{"key":"2026100502515796300_noag115-B25","year":"2025"},{"key":"2026100502515796300_noag115-B26","year":"2025"},{"key":"2026100502515796300_noag115-B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00404-007-0497-z","article-title":"Depot-medroxyprogesterone acetate: an update","volume":"278","author":"Bakry","year":"2008","journal-title":"Arch Gynecol Obstet"},{"key":"2026100502515796300_noag115-B28","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.contraception.2016.02.003","article-title":"The safety of subcutaneously administered depot medroxyprogesterone acetate (104 mg\/0.65 mL): a systematic review","volume":"94","author":"Dragoman","year":"2016","journal-title":"Contraception"},{"key":"2026100502515796300_noag115-B29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0010-7824(03)00136-7","article-title":"Depot-medroxyprogesterone acetate injection (Depo-Provera\u00ae): a highly effective contraceptive option with proven long-term safety","volume":"68","author":"Westhoff","year":"2003","journal-title":"Contraception"},{"key":"2026100502515796300_noag115-B30","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.contraception.2008.10.017","article-title":"Profile of the progesterone derivative chlormadinone acetate\u2014Pharmocodynamic properties and therapeutic applications","volume":"79","author":"Druckmann","year":"2009","journal-title":"Contraception"},{"key":"2026100502515796300_noag115-B31","year":"2024"},{"key":"2026100502515796300_noag115-B32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jsbmb.2013.12.003","article-title":"The \u201cnewer\u201d progestogens and postmenopausal hormone therapy (HRT)","volume":"142","author":"Schindler","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2026100502515796300_noag115-B33","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/brain\/awy108","article-title":"The occurrence of benign brain tumours in transgender individuals during cross-sex hormone treatment","volume":"141","author":"Nota","year":"2018","journal-title":"Brain"},{"key":"2026100502515796300_noag115-B34","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ecl.2019.02.001","article-title":"Transfeminine hormone therapy","volume":"48","author":"Hamidi","year":"2019","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2026100502515796300_noag115-B35","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.jsxm.2021.04.008","article-title":"Low-dose cyproterone acetate treatment for transgender women","volume":"18","author":"Zohar","year":"2021","journal-title":"J Sex Med"},{"key":"2026100502515796300_noag115-B36","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMc071938","article-title":"Growth of a meningioma in a transsexual patient after estrogen\u2013progestin therapy","volume":"357","author":"Gazzeri","year":"2007","journal-title":"N Engl J Med"},{"key":"2026100502515796300_noag115-B37","doi-asserted-by":"publisher","first-page":"102311","DOI":"10.1016\/j.coph.2022.102311","article-title":"Hormonal drugs for the treatment of endometriosis","volume":"67","author":"Capezzuoli","year":"2022","journal-title":"Curr Opin Pharmacol"},{"key":"2026100502515796300_noag115-B38","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/13625187.2017.1317339","article-title":"The use of cyproterone acetate\/ethinyl estradiol in hyperandrogenic skin symptoms \u2013 A review","volume":"22","author":"Bitzer","year":"2017","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"2026100502515796300_noag115-B39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/13625187.2017.1317735","article-title":"Use of cyproterone acetate\/ethinylestradiol in polycystic ovary syndrome: rationale and practical aspects","volume":"22","author":"Ruan","year":"2017","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"2026100502515796300_noag115-B40","doi-asserted-by":"publisher","first-page":"CD001125","DOI":"10.1002\/14651858.CD001125.pub2()","article-title":"Cyproterone acetate for hirsutism","volume":"11","author":"Matjila","year":"2025","journal-title":"Cochrane Database Syst Rev"},{"key":"2026100502515796300_noag115-B41","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1517\/14656560902960162","article-title":"Medroxyprogesterone acetate in the management of cancer cachexia","volume":"10","author":"Madeddu","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"2026100502515796300_noag115-B42","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.3390\/cancers16193362","article-title":"The association between medroxyprogesterone acetate exposure and meningioma","volume":"16","author":"Griffin","year":"2024","journal-title":"Cancers (Basel)"},{"key":"2026100502515796300_noag115-B43","first-page":"1","article-title":"Contraceptive methods women have ever used: United States, 1982-2010","volume":"62","author":"Daniels","year":"2013","journal-title":"Natl Health Stat Rep"},{"key":"2026100502515796300_noag115-B44","first-page":"1","article-title":"Current contraceptive use and variation by selected characteristics among women aged 15\u201344: United States, 2011\u20132013","volume":"86","author":"Daniels","year":"2015","journal-title":"Natl Health Stat Rep"},{"key":"2026100502515796300_noag115-B45","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.contraception.2015.03.017","article-title":"Racial and ethnic differences in contraceptive use among women who desire no future children, 2006\u20132010 national survey of family growth","volume":"92","author":"Grady","year":"2015","journal-title":"Contraception"},{"key":"2026100502515796300_noag115-B46","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1089\/jwh.2020.8642","article-title":"Awareness and use of contraceptive methods and perceptions of long-acting reversible contraception among white and non-White women","volume":"30","author":"Lin","year":"2021","journal-title":"J Womens Health"},{"key":"2026100502515796300_noag115-B47","volume-title":"Use of Contraception in the United States: 1982-2008","author":"Mosher"},{"key":"2026100502515796300_noag115-B48","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1363\/4318111","article-title":"Race, ethnicity and differences in contraception among low-income women: methods received by family PACT clients, California, 2001\u20132007","volume":"43","author":"Dehlendorf","year":"2011","journal-title":"Perspect Sex Reprod Health"},{"key":"2026100502515796300_noag115-B49","doi-asserted-by":"publisher","first-page":"526.e1","DOI":"10.1016\/j.ajog.2014.01.037","article-title":"Racial\/ethnic disparities in contraceptive use: variation by age and women\u2019s reproductive experiences","volume":"210","author":"Dehlendorf","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"2026100502515796300_noag115-B50","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10143-016-0762-3","article-title":"Unique features of pregnancy-related meningiomas: lessons learned from 148 reported cases and theoretical implications of a prolactin modulated pathogenesis","volume":"41","author":"Laviv","year":"2018","journal-title":"Neurosurg Rev"},{"key":"2026100502515796300_noag115-B51","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1227\/NEU.0b013e31826adf65","article-title":"Meningiomas in pregnancy: a clinicopathologic study of 17 cases","volume":"71","author":"Lusis","year":"2012","journal-title":"Neurosurgery"},{"key":"2026100502515796300_noag115-B52","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.surneu.2006.11.063","article-title":"Rapid growth and regression of intracranial meningiomas in lymphangioleiomyomatosis: case report","volume":"68","author":"Pozzati","year":"2007","journal-title":"Surg Neurol"},{"key":"2026100502515796300_noag115-B53","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1080\/026886900417388","article-title":"Spontaneous regression of a solitary cerebral metastases in renal carcinoma followed by meningioma development under medroxyprogesterone acetate therapy","volume":"14","author":"Hensiek","year":"2000","journal-title":"Br J Neurosurg"},{"key":"2026100502515796300_noag115-B54","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3171\/jns.2004.100.2.0328","article-title":"Multiple meningiomas arising during long-term therapy with the progesterone agonist megestrol acetate","volume":"100","author":"Gruber","year":"2004","journal-title":"J Neurosurg"},{"key":"2026100502515796300_noag115-B55","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3171\/2014.12.JNS142112","article-title":"Hormone-dependent shrinkage of a sphenoid wing meningioma after pregnancy: case report","volume":"124","author":"Kerschbaumer","year":"2016","journal-title":"J Neurosurg"},{"key":"2026100502515796300_noag115-B56","doi-asserted-by":"publisher","first-page":"2649426","DOI":"10.1155\/2016\/2649426","article-title":"Postpartum regression of a presumed cavernous meningioma","volume":"2016","author":"Phang","year":"2016","journal-title":"Case Rep Oncol Med"},{"key":"2026100502515796300_noag115-B57","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.3174\/ajnr.A1978","article-title":"Abrupt regression of a meningioma after discontinuation of cyproterone treatment: fig 1","volume":"31","author":"Gon\u00e7alves","year":"2010","journal-title":"AJNR Am J Neuroradiol"},{"key":"2026100502515796300_noag115-B58","doi-asserted-by":"publisher","first-page":"944","DOI":"10.3171\/2022.12.JNS222006","article-title":"Opposed evolution of the osseous and soft parts of progestin-associated osteomeningioma after progestin intake discontinuation","volume":"139","author":"Florea","year":"2023","journal-title":"J Neurosurg"},{"key":"2026100502515796300_noag115-B59","doi-asserted-by":"publisher","first-page":"814.e7-814","DOI":"10.1016\/j.wneu.2017.03.013","article-title":"Dramatic shrinkage with reduced vascularization of large meningiomas after cessation of progestin treatment","volume":"101","author":"Kalamarides","year":"2017","journal-title":"World Neurosurg"},{"key":"2026100502515796300_noag115-B60","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s00701-015-2532-3","article-title":"Growth stabilization and regression of meningiomas after discontinuation of cyproterone acetate: a case series of 12 patients","volume":"157","author":"Bernat","year":"2015","journal-title":"Acta Neurochir (Wien)"},{"key":"2026100502515796300_noag115-B61","doi-asserted-by":"publisher","first-page":"n37","DOI":"10.1136\/bmj.n37","article-title":"Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study","volume":"372","author":"Weill","year":"2021","journal-title":"BMJ."},{"key":"2026100502515796300_noag115-B62","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1136\/jnnp-2021-326138","article-title":"Cyproterone acetate and risk of meningioma: a nationwide cohort study","volume":"93","author":"Mikkelsen","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2026100502515796300_noag115-B63","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1111\/ene.15423","article-title":"Risk of intracranial meningioma with three potent progestogens: a population-based case\u2013control study","volume":"29","author":"Hoisnard","year":"2022","journal-title":"Eur J Neurol"},{"key":"2026100502515796300_noag115-B64","doi-asserted-by":"publisher","first-page":"100928","DOI":"10.1016\/j.lanepe.2024.100928","article-title":"Prolonged use of nomegestrol acetate and risk of intracranial meningioma: a population-based cohort study","volume":"42","author":"Nguyen","year":"2024","journal-title":"Lancet Reg Health - Eur"},{"key":"2026100502515796300_noag115-B65","doi-asserted-by":"publisher","first-page":"103791","DOI":"10.1016\/j.eclinm.2026.103791","article-title":"Progestogen use and the risk of intracranial meningioma: a systematic review and meta-analysis","volume":"92","author":"Hudelist","year":"2026","journal-title":"EClinicalMedicine"},{"key":"2026100502515796300_noag115-B66","article-title":"Restrictions in use of cyproterone due to meningioma risk","year":"2020","journal-title":"Eur Med Agency"},{"key":"2026100502515796300_noag115-B67","article-title":"Assessment report referral under article 31 of directive 2001\/83\/EC resulting from pharmacovigilance data INN: nomegestrol-containing products and chlormadinone-containing products","year":"2022","journal-title":"Eur Med Agency"},{"key":"2026100502515796300_noag115-B68","doi-asserted-by":"publisher","first-page":"e078078","DOI":"10.1136\/bmj-2023-078078","article-title":"Use of progestogens and the risk of intracranial meningioma: national case-control study","volume":"384","author":"Roland","year":"2024","journal-title":"BMJ."},{"key":"2026100502515796300_noag115-B69","doi-asserted-by":"publisher","first-page":"e083981","DOI":"10.1136\/bmj-2024-083981","article-title":"Oral contraceptives with progestogens desogestrel or levonorgestrel and risk of intracranial meningioma: national case-control study","volume":"389","author":"Roland","year":"2025","journal-title":"BMJ"},{"key":"2026100502515796300_noag115-B70","doi-asserted-by":"publisher","first-page":"noaf228","DOI":"10.1093\/neuonc\/noaf228","article-title":"Hormonal contraceptives and the risk of meningioma: a Swedish register-based case-control study","volume":"28","author":"Tettamanti","year":"2026","journal-title":"Neuro-Oncol"},{"key":"2026100502515796300_noag115-B71","doi-asserted-by":"publisher","first-page":"noaf267","DOI":"10.1093\/neuonc\/noaf267","article-title":"Mounting evidence implicates medroxyprogesterone acetate in meningioma risk, but mechanisms require further investigation","volume":"28","author":"Braman","year":"2026","journal-title":"Neuro-Oncol"},{"key":"2026100502515796300_noag115-B72","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1001\/jamaneurol.2025.3011","article-title":"Depot medroxyprogesterone acetate and risk of meningioma in the US","volume":"82","author":"Xiao","year":"2025","journal-title":"JAMA Neurol"},{"key":"2026100502515796300_noag115-B73","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s11060-025-05402-5","article-title":"Risk of intracranial meningioma requiring surgical intervention among recent hormonal contraceptives users","volume":"176","author":"Chen","year":"2026","journal-title":"J Neurooncol"},{"key":"2026100502515796300_noag115-B74","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/annonc\/mdx763","article-title":"Progestin-associated shift of meningioma mutational landscape","volume":"29","author":"Peyre","year":"2018","journal-title":"Ann Oncol"},{"key":"2026100502515796300_noag115-B75","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41467-017-00174-7","article-title":"Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomas","volume":"8","author":"Agnihotri","year":"2017","journal-title":"Nat Commun"},{"key":"2026100502515796300_noag115-B76","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00401-017-1715-9","article-title":"Meningiomas induced by low-dose radiation carry structural variants of NF2 and a distinct mutational signature","volume":"134","author":"Sahm","year":"2017","journal-title":"Acta Neuropathol"},{"key":"2026100502515796300_noag115-B77","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1126\/science.1233009","article-title":"Genomic analysis of Non- NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO","volume":"339","author":"Clark","year":"2013","journal-title":"Science (1979)"},{"key":"2026100502515796300_noag115-B78","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3171\/2019.8.JNS191266","article-title":"Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas","volume":"133","author":"Youngblood","year":"2020","journal-title":"J Neurosurg"},{"key":"2026100502515796300_noag115-B79","doi-asserted-by":"publisher","first-page":"i67","DOI":"10.1093\/noajnl\/vdac088","article-title":"Radiotherapy and radiosurgery for meningiomas","volume":"5","author":"Chen","year":"2023","journal-title":"Neurooncol Adv"},{"key":"2026100502515796300_noag115-B80","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1210\/me.2004-0306","article-title":"Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases","volume":"19","author":"Skildum","year":"2005","journal-title":"Mol Endocrinol"},{"key":"2026100502515796300_noag115-B81","doi-asserted-by":"publisher","first-page":"108503","DOI":"10.1016\/j.steroids.2019.108503","article-title":"Molecular mechanisms underlying progesterone receptor action in breast cancer: insights into cell proliferation and stem cell regulation","volume":"152","author":"Cenciarini","year":"2019","journal-title":"Steroids"},{"key":"2026100502515796300_noag115-B82","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s00401-023-02635-4","article-title":"Normal meninges harbor oncogenic somatic mutations in meningioma-driver genes","volume":"146","author":"Boetto","year":"2023","journal-title":"Acta Neuropathol"},{"key":"2026100502515796300_noag115-B83","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11060-022-04187-1","article-title":"Hormone therapies in meningioma-where are we?","volume":"161","author":"Miyagishima","year":"2023","journal-title":"J Neurooncol"},{"key":"2026100502515796300_noag115-B84","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.1200\/JCO.2015.61.6490","article-title":"Double-blind phase III randomized trial of the antiprogestin agent mifepristone in the treatment of unresectable meningioma: SWOG S9005","volume":"33","author":"Ji","year":"2015","journal-title":"J Clin Oncol"},{"key":"2026100502515796300_noag115-B85","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/S0959-8049(01)00146-0","article-title":"Progesterone receptor isoform expression in human meningiomas","volume":"37","author":"Verheijen","year":"2001","journal-title":"Eur J Cancer"},{"key":"2026100502515796300_noag115-B86","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/0090-3019(89)90318-2","article-title":"Endocrine manipulation of meningiomas with medroxyprogesterone acetate effect of MPA on growth of primary meningioma cells in monolayer tissue culture","volume":"31","author":"Waelti","year":"1989","journal-title":"Surg Neurol"},{"key":"2026100502515796300_noag115-B87","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/B978-0-12-804280-9.00008-1","article-title":"Preclinical models of meningioma: cell culture and animal systems","volume":"169","author":"Choudhury","year":"2020","journal-title":"Handb Clin Neurol"},{"key":"2026100502515796300_noag115-B88","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11060-022-04124-2","article-title":"Meningioma in patients exposed to progestin drugs: results from a real-life screening program","volume":"160","author":"Samoyeau","year":"2022","journal-title":"J Neurooncol"},{"key":"2026100502515796300_noag115-B89","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3171\/jns.2006.105.4.538","article-title":"Indications for surgery in patients with asymptomatic meningiomas based on an extensive experience","volume":"105","author":"Yano","year":"2006","journal-title":"J Neurosurg"},{"key":"2026100502515796300_noag115-B90","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/neuonc\/noab132","article-title":"An international multicenter matched cohort analysis of incidental meningioma progression during active surveillance or after stereotactic radiosurgery: the IMPASSE study","volume":"24","author":"Sheehan","year":"2022","journal-title":"Neuro-Oncol"},{"key":"2026100502515796300_noag115-B91","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.whi.2023.08.003","article-title":"Characteristics associated with physician bias in contraceptive recommendations","volume":"34","author":"DiCenzo","year":"2024","journal-title":"Womens Health Issues"},{"key":"2026100502515796300_noag115-B92","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.contraception.2022.07.014","article-title":"Exploring financial stress and resource deprivation as barriers to preferred contraceptive use in Wisconsin in 2021","volume":"115","author":"Swan","year":"2022","journal-title":"Contraception"},{"key":"2026100502515796300_noag115-B93","doi-asserted-by":"publisher","first-page":"113366","DOI":"10.1016\/j.socscimed.2020.113366","article-title":"Contraceptive selection and practice: associations with self-identified race and socioeconomic disadvantage","volume":"266","author":"Wright","year":"2020","journal-title":"Soc Sci Med"},{"key":"2026100502515796300_noag115-B94","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/psrh.12269","article-title":"Neighborhood-level racialized socioeconomic deprivation and contraceptive use in the United States, 2011\u20132019","volume":"56","author":"Cartwright","year":"2024","journal-title":"Perspect Sex Reprod Health"},{"key":"2026100502515796300_noag115-B95","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s40615-019-00570-3","article-title":"Contraceptive desert? Black-White differences in characteristics of nearby pharmacies","volume":"6","author":"Barber","year":"2019","journal-title":"J Racial Ethn Health Disparities"},{"key":"2026100502515796300_noag115-B96","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/0029-7844(94)00383-O","article-title":"Hormone replacement therapy and endometrial cancer risk: a meta-analysis","volume":"85","author":"Grady","year":"1995","journal-title":"Obstet Gynecol"},{"key":"2026100502515796300_noag115-B97","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1001\/jama.288.7.872","article-title":"Postmenopausal hormone replacement therapy","volume":"288","author":"Nelson","year":"2002","journal-title":"JAMA"},{"key":"2026100502515796300_noag115-B98","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1056\/NEJM200107053450106","article-title":"Postmenopausal hormone-replacement therapy","volume":"345","author":"Manson","year":"2001","journal-title":"N Engl J Med"},{"key":"2026100502515796300_noag115-B99","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Writing group for the women\u2019s health initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women\u2019s health initiative randomized controlled trial","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"2026100502515796300_noag115-B100","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1097\/GME.0000000000002028","article-title":"The 2022 hormone therapy position statement of the North American menopause society","volume":"29","author":"North American Menopause Society","year":"2022","journal-title":"Menopause"},{"key":"2026100502515796300_noag115-B101","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1001\/jama.2022.24140","article-title":"Management of menopausal symptoms: a review","volume":"329","author":"Crandall","year":"2023","journal-title":"JAMA"},{"key":"2026100502515796300_noag115-B102","doi-asserted-by":"publisher","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"key":"2026100502515796300_noag115-B103","doi-asserted-by":"publisher","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study","volume":"339","author":"Van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"key":"2026100502515796300_noag115-B104","doi-asserted-by":"publisher","first-page":"h2135","DOI":"10.1136\/bmj.h2135","article-title":"Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases","volume":"350","author":"Vinogradova","year":"2015","journal-title":"BMJ"},{"key":"2026100502515796300_noag115-B105","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/humupd\/dmt028","article-title":"Venous thromboembolism in women: a specific reproductive health risk","volume":"19","author":"ESHRE Capri Workshop Group","year":"2013","journal-title":"Hum Reprod Update"},{"key":"2026100502515796300_noag115-B106","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1001\/jama.2018.20578","article-title":"Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis","volume":"321","author":"Zheng","year":"2019","journal-title":"JAMA"},{"key":"2026100502515796300_noag115-B107","year":"2025"},{"key":"2026100502515796300_noag115-B108","year":"2024"},{"key":"2026100502515796300_noag115-B109","year":"2024"},{"key":"2026100502515796300_noag115-B110","year":"2024"},{"key":"2026100502515796300_noag115-B111","year":"2024"},{"key":"2026100502515796300_noag115-B112","year":"2025"},{"key":"2026100502515796300_noag115-B113","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1001\/jama.2021.21392","article-title":"Contraception selection, effectiveness, and adverse effects: a review","volume":"326","author":"Teal","year":"2021","journal-title":"JAMA"},{"key":"2026100502515796300_noag115-B114","doi-asserted-by":"publisher","first-page":"S878.e1","DOI":"10.1016\/j.ajog.2019.11.1279","article-title":"Beyond same-day long-acting reversible contraceptive access: a person-centered framework for advancing high-quality, equitable contraceptive care","volume":"222","author":"Holt","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"2026100502515796300_noag115-B115","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1097\/AOG.0000000000003072","article-title":"ACOG practice bulletin No. 206: use of hormonal contraception in women with coexisting medical conditions","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"2026100502515796300_noag115-B116","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.fertnstert.2016.09.027","article-title":"Combined hormonal contraception and the risk of venous thromboembolism: a guideline","volume":"107","author":"Pfeifer","year":"2017","journal-title":"Fertil Steril"},{"key":"2026100502515796300_noag115-B117","doi-asserted-by":"publisher","first-page":"23780231231180378","DOI":"10.1177\/23780231231180378","article-title":"Reproductive oppression enters the twenty-first century: pressure to use long-acting reversible contraception (LARC) in the context of LARC first","volume":"9","author":"Eeckhaut","year":"2023","journal-title":"Socius Sociol Res Dyn World"},{"key":"2026100502515796300_noag115-B118","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3122\/jabfm.2025.250073R1","article-title":"Advancing equitable, person-centered contraceptive care using data-driven quality improvement","volume":"38","author":"Dehlendorf","year":"2026","journal-title":"J Am Board Fam Med"},{"key":"2026100502515796300_noag115-B119","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.2105\/AJPH.2016.303393","article-title":"Provider bias in long-acting reversible contraception (LARC) promotion and removal: perceptions of young adult women","volume":"106","author":"Higgins","year":"2016","journal-title":"Am J Public Health"},{"key":"2026100502515796300_noag115-B120","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.contraception.2017.07.007","article-title":"Under (implicit) pressure: young Black and Latina women\u2019s perceptions of contraceptive care","volume":"96","author":"Gomez","year":"2017","journal-title":"Contraception"},{"key":"2026100502515796300_noag115-B121","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.bpobgyn.2006.03.002","article-title":"Evidence based contraceptive choices","volume":"20","author":"Scott","year":"2006","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2026100502515796300_noag115-B122","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/neuonc\/noad223","article-title":"Association of county-level socioeconomic status with meningioma incidence and outcomes","volume":"26","author":"Pugazenthi","year":"2024","journal-title":"Neuro-Oncol"},{"key":"2026100502515796300_noag115-B123","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3171\/2011.3.JNS101748","article-title":"Treatment and survival of patients with nonmalignant intracranial meningioma: results from the surveillance, epidemiology, and end results program of the national cancer institute: clinical article","volume":"115","author":"Cahill","year":"2011","journal-title":"J Neurosurg"},{"key":"2026100502515796300_noag115-B124","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s11060-023-04393-5","article-title":"Associations of race and socioeconomic status with outcomes after intracranial meningioma resection: a systematic review and meta-analysis","volume":"163","author":"Lei","year":"2023","journal-title":"J Neurooncol"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noag115\/68363887\/noag115.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/28\/10\/2338\/68363887\/noag115.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/28\/10\/2338\/68363887\/noag115.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:52:05Z","timestamp":1791183125000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/28\/10\/2338\/8690186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":124,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5,21]]},"published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noag115","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,5,21]]}}}